- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 487/06 - Peri-condensed systems
Patent holdings for IPC class C07D 487/06
Total number of patents in this class: 501
10-year publication summary
37
|
19
|
36
|
45
|
39
|
23
|
35
|
43
|
48
|
20
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Idemitsu Kosan Co., Ltd. | 4214 |
29 |
Bristol-myers Squibb Company | 4875 |
23 |
Merck Patent GmbH | 5828 |
20 |
Intervet International B.V. | 1282 |
14 |
Pfizer Inc. | 3374 |
13 |
UDC Ireland Limited | 480 |
12 |
Universal Display Corporation | 1902 |
11 |
LG Chem, Ltd. | 17615 |
9 |
Takeda Pharmaceutical Company Limited | 2714 |
8 |
Medshine Discovery Inc. | 601 |
7 |
Samsung Display Co., Ltd. | 34595 |
6 |
Massachusetts Institute of Technology | 10041 |
6 |
Rohm and Haas Electronic Materials Korea Ltd. | 330 |
6 |
SFC Co., Ltd. | 321 |
6 |
BeiGene Switzerland GmbH | 171 |
6 |
Samsung Electronics Co., Ltd. | 145630 |
5 |
ArQule, Inc. | 136 |
5 |
Assia Chemical Industries Ltd. | 176 |
5 |
Duk San Neolux Co., Ltd. | 645 |
5 |
HotSpot Therapeutics, Inc. | 26 |
5 |
Other owners | 300 |